Abstract
摘要
相似文献
1
Ketotifen and neurofibromatosis.
Arch Dermatol. 1988 May;124(5):651-2.
2
Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.
Arch Dermatol. 1987 Aug;123(8):1011-6.
3
[Ketotifen inhibits urticaria and tumor progression in neurofibromatosis].
Dermatol Monatsschr. 1989;175(9):581-4.
4
Ketotifen induced inhibition of histamine release in a non-IgE model of middle ear effusion.
Pediatr Allergy Immunol. 2006 Feb;17(1):43-8. doi: 10.1111/j.1399-3038.2005.00350.x.
5
New hope for neurofibromatosis? The mast cell connection.
JAMA. 1987 Aug 14;258(6):823.
6
Prevention of mast-cell degranulation by ketotifen in patients with physical urticarias.
Ann Intern Med. 1986 Apr;104(4):507-10. doi: 10.7326/0003-4819-104-4-507.
7
Ketotifen suppression of NF1 neurofibroma growth over 30 years.
Am J Med Genet A. 2015 Jul;167(7):1570-7. doi: 10.1002/ajmg.a.37045. Epub 2015 May 14.
8
Mast cell mediators in asthma. Clinical uses of the inhibitors.
Allergol Immunopathol (Madr). 1981;Suppl 9:23-7.
9
Drug therapy for neurofibromatosis?
Arch Dermatol. 1993 May;129(5):625-6.
10
Mast cells and basophils: models for studying the antianaphylactic potency of drugs.
Pediatr Pharmacol (New York). 1983;3(3-4):287-92.
Zotero 插件